Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates
- 1 November 1995
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 23 (5), 487-496
- https://doi.org/10.1016/0168-8278(95)80052-2
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Antiviral therapy of hepatitis C — present and futureJournal of Hepatology, 1993
- Treatment of chronic hepatitis C with high-dose interferon ?-2bDigestive Diseases and Sciences, 1993
- Results of long term interferon treatment in non A non B/C chronic active hepatitis. The French Group for the study of NANB/C chronic hepatitis treatment.Gut, 1993
- Treatment of chronic hepatitis CJournal of Hepatology, 1991
- Classification of chronic viral hepatitis: a need for reassessmentJournal of Hepatology, 1991
- Can the response to interferon treatment be predicted in patients with chronic active hepatitis C?Australian and New Zealand Journal of Medicine, 1991
- Interferon alpha-2b treatment of chronic posttransfusion non-A, non-B/C hepatitis: Long-term outcome and effect of increased interferon doses in non-respondersScandinavian Journal of Infectious Diseases, 1991
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989
- Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha InterferonNew England Journal of Medicine, 1986